VRS
KRYS icon

Virginia Retirement Systems’s Krystal Biotech KRYS Stock Holding History

Virginia Retirement Systems’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Buy
10,400
+900
+9% +$269K 0.02% 370
2026
Q1 		$2.45M Buy
9,500
+500
+6% +$133K 0.02% 394
2025
Q4 		$2.22M Buy
9,000
+7,000
+350% +$1.47M 0.01% 399
2025
Q3 		$353K Sell
2,000
-5,800
-74% -$868K ﹤0.01% 822
2025
Q2 		$1.07M Hold
7,800
– – 0.01% 557
2025
Q1 		$1.41M Buy
+7,800
New +$1.31M 0.01% 472

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virginia Retirement Systems's KRYS Position: Q2 2026 in Review

Virginia Retirement Systems increased its Krystal Biotech (KRYS) stake by 9.5% in Q2 2026, buying an estimated $269K and bringing the position to 10,400 shares worth $3.87M. The position accounts for 0.02% of the portfolio, ranked #370.

Virginia Retirement Systems first reported a position in KRYS in Q1 2025 and has held it in 6 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Virginia Retirement Systems held 10,400 shares of Krystal Biotech worth $3.87M as of Q2 2026.
  • Virginia Retirement Systems bought 900 Krystal Biotech shares in Q2 2026, an estimated $269K.
  • Krystal Biotech made up 0.02% of Virginia Retirement Systems's portfolio in Q2 2026, its #370 holding.
  • Virginia Retirement Systems first reported a position in Krystal Biotech in Q1 2025 and has held it in 6 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.